Medical News

RSS

MedPage Today launches Video Conference Reporter for real-time coverage of major oncology meetings

MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), announces the launch of "Video Conference Reporter," to provide recorded real-time video coverage of major oncology research presented at leading scientific sessions worldwide.

31 May 2014

Lawmaker pushes mental health reform bill in the wake of recent Calif. shooting

Rep. Tim Murphy, R-Pa., held a forum Thursday in an effort to build momentum and consensus around this legislation.

31 May 2014

GrowBLOX Sciences’ patent-pending technology for medical-grade cannabis comes off production line

GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that the first of its patent pending proprietary agricultural indoor growing system for medical-grade cannabis has come off the production line.

31 May 2014

NCI awards 'provocative questions' grants to Jackson lab researchers

Jackson Laboratory Assistant Professors Jennifer Trowbridge, Ph.D., and Chengkai Dai, M.D., Ph.D., have each received new federal research grants through a funding mechanism designed to address "provocative questions" about cancer set out by the National Cancer Institute (NCI).

31 May 2014

Palliative care can reduce pain and other distressing symptoms

When three-year-old Rachel was diagnosed with cancer, it was one of the worst days of her mother's life. Tests, medications, surgery—young Rachel's life turned upside down.

31 May 2014

U.S. Court awards Teva favorable decision for generic Celebrex

Teva Pharmaceutical Industries Ltd. announced that the U.S. District Court for the Northern District of West Virginia denied a motion filed by Mylan and issued an opinion and order affirming a decision by the FDA under which Teva should receive sole 180-day "first-to-file" exclusivity for generic Celebrex® (celecoxib) 100, 200 and 400 mg capsules.

31 May 2014

GE Healthcare to supply technetium-99m generators following FDA approval

Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.

31 May 2014

Valeant, Pershing Square make revised proposal to acquire all outstanding shares of Allergan

Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPin® sales (the "Re-Revised Proposal").

31 May 2014

MediNatura to purchase Heel Group's USA operation

MediNatura™ Incorporated, a Delaware Corporation headquartered in greater Philadelphia, today announced an agreement to purchase the Heel Group's USA operations, which is expected to be completed in late August 2014.

31 May 2014

Vitamix Laboratories opens new manufacturing facility in Commack, New York

Vitamix Laboratories, one of the most highly regarded vitamin manufacturers in the industry, recently announced a major milestone: the company has moved into a new 23,175 square foot state-of-the-art manufacturing facility in Commack, New York.

31 May 2014

Northwestern Medicine allergist offers tips to fight allergies

Nasal congestion, sneezing, and itchy and watery eyes — for the nearly 50 million Americans with seasonal allergies, these are the true rites of spring

31 May 2014

Viewpoints: VA's problems begin with Congress; costly hepatitis drug may be a good buy

Politically, this critique of the VA is a no-brainer. After all, denying, delaying or incompetently delivering benefits to veterans who are entitled to them and have sacrificed so much for us is grotesque: the moral equivalent of kicking dogs and stealing food from children.

31 May 2014

Research report on sports nutrition market in Europe

Sports Nutrition Market in Europe 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts.

31 May 2014

ArQule to present tivantinib clinical trial data at ASCO 2014

ArQule, Inc. today announced that tivantinib will be included in seven presentations during the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held from May 30, 2014 to June 3, 2014 in Chicago, Illinois.

31 May 2014

Agena Bioscience expands ultrasensitive somatic mutation detection technology

Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today announced expansion of the UltraSEEK™ technology, the first ultrasensitive somatic mutation detection technology for high-throughput and definitive interrogation of rare mutations that occur at less than 1% abundance in matched tissue, circulating plasma, and tumor samples.

31 May 2014

vielife receives quality assurance certification from NCQA

vielife has received certification from the National Committee for Quality Assurance (NCQA) in the categories of health appraisals and self-management tools. This is the fourth consecutive time vielife has been awarded the certification.

31 May 2014

Health advocates allege 4 Fla. insurers discriminate against HIV patients

In a complaint to federal officials, the groups say the companies set high out-of-pocket costs for drugs to treat HIV and AIDS in an effort to discourage gay patients from picking the plans.

31 May 2014

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn't been thoroughly examined until now.

31 May 2014

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).

31 May 2014

Deciphera initiates altiratinib MET/TIE2/VEGFR/TRK kinase inhibitor Phase 1 trial for solid tumors

Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments for cancer, today announced the initiation of a Phase 1 clinical trial of its MET/TIE2/VEGFR2/TRK inhibitor altiratinib (DCC-2701).

31 May 2014